6α-Hydroxycannabidiol

• CAT Number: R034721
• CAS Number: 58940-28-6
• Molecular Formula: C₂₁H₃₀O₃
• Molecular Weight: 330.46
• Purity: ≥95%
• Synonyms: [1R-(1α,4β,6β)]-2-[4-Hydroxy-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
• Storage: -20°C
• IUPAC Name: 2-[(1R,4S,6R)-4-hydroxy-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
• InChI: InChI=1S/C21H30O3/c1-5-6-7-8-15-10-19(23)21(20(24)11-15)17-9-14(4)18(22)12-16(17)13(2)3/h9-11,16-18,22-24H,2,5-8,12H2,1,3-4H3/t16-,17+,18-/m0/s1
• InChIKey: YYLPAYRRVSQJRR-KSZLIROESA-N
• SMILES: CCCCCC1=CC(=C(C(=C1)O)C2C=C(C(CC2C(=C)C)O)C)O

6α-Hydroxycannabidiol（Cat No.:R034721）is a bioactive metabolite of cannabidiol (CBD), one of the major non-psychoactive components of cannabis. This compound retains many of the therapeutic properties of CBD, including anti-inflammatory, analgesic, and neuroprotective effects. It is studied for its potential in treating a range of conditions such as epilepsy, chronic pain, and anxiety disorders. The hydroxyl group at the 6α position enhances its solubility and bioavailability, potentially improving its efficacy. Research into 6α-Hydroxycannabidiol continues to explore its benefits and applications in medical and pharmaceutical fields.